Eye-Go Secures Strategic Investment From Topcon Healthcare

COPENHAGEN, Denmark and LA JOLLA, Calif.—Eye-Go, a Danish med-tech company specializing in ophthalmic drug delivery, has announced a strategic investment from Topcon Healthcare, Inc., the global company specializing in digital health care solutions and robotic diagnostics. This partnership aligns with Topcon Healthcare’s mission to improve access to high-quality eyecare while reducing overall health care costs, the announcement stated, with the collaboration reflecting a shared vision to revolutionize chronic eye disease management by integrating drug delivery, real-world adherence data, and diagnostic insights into a single, connected care pathway.